- Home
- USAS vs LUNG Comparison
USAS vs LUNG Comparison
Compare USAS & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USAS
- LUNG
- Stock Information
- Founded
- USAS 1998
- LUNG 1995
- Country
- USAS Canada
- LUNG United States
- Employees
- USAS N/A
- LUNG N/A
- Industry
- USAS Metal Mining
- LUNG Industrial Specialties
- Sector
- USAS Basic Materials
- LUNG Health Care
- Exchange
- USAS Nasdaq
- LUNG Nasdaq
- Market Cap
- USAS 286.7M
- LUNG 299.3M
- IPO Year
- USAS N/A
- LUNG 2020
- Fundamental
- Price
- USAS $0.56
- LUNG $7.77
- Analyst Decision
- USAS Strong Buy
- LUNG Strong Buy
- Analyst Count
- USAS 1
- LUNG 7
- Target Price
- USAS $0.90
- LUNG $12.64
- AVG Volume (30 Days)
- USAS 1.1M
- LUNG 464.2K
- Earning Date
- USAS 05-14-2025
- LUNG 04-30-2025
- Dividend Yield
- USAS N/A
- LUNG N/A
- EPS Growth
- USAS N/A
- LUNG N/A
- EPS
- USAS N/A
- LUNG N/A
- Revenue
- USAS $97,123,000.00
- LUNG $83,789,000.00
- Revenue This Year
- USAS $21.84
- LUNG $17.96
- Revenue Next Year
- USAS $46.00
- LUNG $18.35
- P/E Ratio
- USAS N/A
- LUNG N/A
- Revenue Growth
- USAS 14.33
- LUNG 22.01
- 52 Week Low
- USAS $0.20
- LUNG $5.46
- 52 Week High
- USAS $0.60
- LUNG $10.01
- Technical
- Relative Strength Index (RSI)
- USAS 58.10
- LUNG 52.56
- Support Level
- USAS $0.45
- LUNG $7.65
- Resistance Level
- USAS $0.59
- LUNG $8.12
- Average True Range (ATR)
- USAS 0.04
- LUNG 0.49
- MACD
- USAS 0.01
- LUNG -0.06
- Stochastic Oscillator
- USAS 80.40
- LUNG 45.71
About USAS Americas Gold and Silver Corporation no par value
Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets are The Cosala operations, The Galena Complex, and Relief Canyon. The company also holds interests in the San Felipe Development Project located in Sonora, Mexico. It has geographic focus is the Western Hemisphere, particularly the United States and Mexico.
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.